Pathogenesis of malaria-associated acute respiratory distress syndrome

Trends in Parasitology

Volumn 29, Issue 7, 2013, Pages 346-358

  Van den Steen, Philippe E ^a   Deroost, Katrien ^a   Deckers, Julie ^a,b   Van Herck, Evelien ^a   Struyf, Sofie ^a   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Inflammation; Malaria; Mouse models; Pulmonary edema; Sequestration

Indexed keywords

CARBON MONOXIDE; CELL ADHESION MOLECULE; CHEMOKINE; CHLOROQUINE; CYTOKINE; DEXAMETHASONE; DIHYDROARTEMISININ; INDOMETACIN; PHENOXYBENZAMINE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TOLL LIKE RECEPTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; BRAIN MALARIA; CELL ADHESION; DISEASE ASSOCIATION; EDEMA; HUMAN; IMMUNE EVASION; INFLAMMATORY INFILTRATE; LUNG BLOOD VESSEL; LUNG EDEMA; LUNG GAS EXCHANGE; LUNG SEQUESTRATION; MALARIA; MALARIA ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPEN LUNG BIOPSY; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM VIVAX; POSITIVE END EXPIRATORY PRESSURE; PULMONARY ARTERY OCCLUSION PRESSURE; REVIEW; TRYPANOSOMA CRUZI;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL ADHESION MOLECULES; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; LEUKOCYTES; MALARIA; MICE; PLASMODIUM; PULMONARY EDEMA; RESPIRATORY DISTRESS SYNDROME, ADULT;

MURINAE; MUS;

EID: 84879462863     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2013.04.006     Document Type: Review

References (97)

1. Taylor W.R., et al. Pulmonary manifestations of malaria: recognition and management. Treat. Respir. Med. 2006, 5:419-428.
2. Mohan A., et al. Acute lung injury and acute respiratory distress syndrome in malaria. J. Vector Borne Dis. 2008, 45:179-193.
3. Taylor W.R., et al. Respiratory manifestations of malaria. Chest 2012, 142:492-505.
4. Nayak K.C., et al. A study on pulmonary manifestations in patients with malaria from northwestern India (Bikaner). J. Vector Borne Dis. 2011, 48:219-223.
5. Marsh K., et al. Indicators of life-threatening malaria in African children. N. Engl. J. Med. 1995, 332:1399-1404.
6. English M., et al. Deep breathing in children with severe malaria: indicator of metabolic acidosis and poor outcome. Am. J. Trop. Med. Hyg. 1996, 55:521-524.
7. Matthay M.A., Zemans R.L. The acute respiratory distress syndrome: pathogenesis and treatment. Annu. Rev. Pathol. 2011, 6:147-163.
8. Wheeler A.P., Bernard G.R. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007, 369:1553-1564.
9. Maguire G.P., et al. Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in Papua, Indonesia. J. Infect. Dis. 2005, 192:1966-1974.
10. Daneshvar C., et al. Clinical and laboratory features of human Plasmodium knowlesi infection. Clin. Infect. Dis. 2009, 49:852-860.
11. William T., et al. Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia. Emerg. Infect. Dis. 2011, 17:1248-1255.
12. Charoenpan P., et al. Pulmonary edema in severe falciparum malaria. Hemodynamic study and clinicophysiologic correlation. Chest 1990, 97:1190-1197.
13. Jindal S.K., et al. Adult respiratory distress syndrome in the tropics. Clin. Chest Med. 2002, 23:445-455.
14. Tan L.K., et al. Acute lung injury and other serious complications of Plasmodium vivax malaria. Lancet Infect. Dis. 2008, 8:449-454.
15. Hanson J.P., et al. Fluid resuscitation of adults with severe falciparum malaria: effects on acid-base status, renal function, and extravascular lung water. Crit. Care Med. 2013, 41:972-981.
16. Valecha N., et al. Histopathology of fatal respiratory distress caused by Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 2009, 81:758-762.
17. Duarte M.I., et al. Ultrastructure of the lung in falciparum malaria. Am. J. Trop. Med. Hyg. 1985, 34:31-35.
18. MacPherson G.G., et al. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 1985, 119:385-401.
19. Punyagupta S., et al. Acute pulmonary insufficiency in falciparum malaria: summary of 12 cases with evidence of disseminated intravascular coagulation. Am. J. Trop. Med. Hyg. 1974, 23:551-559.
20. Deaton J.G. Fatal pulmonary edema as a complication of acute falciparum malaria. Am. J. Trop. Med. Hyg. 1970, 19:196-201.
21. Feldman R.M., Singer C. Noncardiogenic pulmonary edema and pulmonary fibrosis in falciparum malaria. Rev. Infect. Dis. 1987, 9:134-139.
22. Taylor W.R., White N.J. Malaria and the lung. Clin. Chest Med. 2002, 23:457-468.
23. Kaushik R., et al. Plasmodium vivax malaria complicated by acute kidney injury: experience at a referral hospital in Uttarakhand, India. Trans. R. Soc. Trop. Med. Hyg. 2013, 107:188-194.
24. Anstey N.M., et al. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J. Infect. Dis. 2007, 195:589-596.
25. Anstey N.M., et al. The pathophysiology of vivax malaria. Trends Parasitol. 2009, 25:220-227.
26. Buffet P.A., et al. Retention of erythrocytes in the spleen: a double-edged process in human malaria. Curr. Opin. Hematol. 2009, 16:157-164.
27. Handayani S., et al. High deformability of Plasmodium vivax-infected red blood cells under microfluidic conditions. J. Infect. Dis. 2009, 199:445-450.
28. Carvalho B.O., et al. On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J. Infect. Dis. 2010, 202:638-647.
29. Chotivanich K., et al. Plasmodium vivax adherence to placental glycosaminoglycans. PLoS ONE 2012, 7:e34509.
30. Cox-Singh J., et al. Severe malaria - a case of fatal Plasmodium knowlesi infection with post-mortem findings: a case report. Malar. J. 2010, 9:10.
31. Schofield L., Grau G.E. Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 2005, 5:722-735.
32. Craig A.G., et al. The role of animal models for research on severe malaria. PLoS Pathog. 2012, 8:e1002401.
33. Van den Steen P.E., et al. Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2010, 181:957-968.
34. Epiphanio S., et al. VEGF promotes malaria-associated acute lung injury in mice. PLoS Pathog. 2010, 6:e1000916.
35. Hee L., et al. Reduced activity of the epithelial sodium channel in malaria-induced pulmonary oedema in mice. Int. J. Parasitol. 2011, 41:81-88.
36. Clark I.A., et al. Possible roles of tumor necrosis factor in the pathology of malaria. Am. J. Pathol. 1987, 129:192-199.
37. Kremsner P.G., et al. Interferon-gamma induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine. Eur. J. Immunol. 1992, 22:2873-2878.
38. Fu Y., et al. Comparative histopathology of mice infected with the 17XL and 17XNL strains of Plasmodium yoelii. J. Parasitol. 2012, 98:310-315.
39. Lovegrove F.E., et al. Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model. PLoS Pathog. 2008, 4:e1000068.
40. Hansen D.S., et al. The natural killer complex regulates severe malarial pathogenesis and influences acquired immune responses to Plasmodium berghei ANKA. Infect. Immun. 2005, 73:2288-2297.
41. Andrade Junior H.F., et al. Comparative and sequential histopathology of Plasmodium chabaudi-infected Balb/c mice. Braz. J. Med. Biol. Res. 1991, 24:1209-1218.
42. Geurts N., et al. Insufficiently defined genetic background confounds phenotypes in transgenic studies as exemplified by malaria infection in Tlr9 knockout mice. PLoS ONE 2011, 6:e27131.
43. Franke-Fayard B., et al. Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11468-11473.
44. Deroost K., et al. Hemozoin induces lung inflammation and correlates with malaria-associated acute respiratory distress syndrome. Am. J. Respir. Cell Mol. Biol. 2013, 48:589-600.
45. Corbett C.E., et al. Cytoadherence in human falciparum malaria as a cause of respiratory distress. J. Trop. Med. Hyg. 1989, 92:112-120.
46. Jemmely N.Y., et al. Small variant surface antigens and Plasmodium evasion of immunity. Future Microbiol. 2010, 5:663-682.
47. Fonager J., et al. Reduced CD36-dependent tissue sequestration of Plasmodium-infected erythrocytes is detrimental to malaria parasite growth in vivo. J. Exp. Med. 2012, 209:93-107.
48. Cunha-Rodrigues M., et al. Bone marrow chimeric mice reveal a dual role for CD36 in Plasmodium berghei ANKA infection. Malar. J. 2007, 6:32.
49. Piguet P.F., et al. Role of CD40-CD40L in mouse severe malaria. Am. J. Pathol. 2001, 159:733-742.
50. Opal S.M. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int. J. Med. Microbiol. 2007, 297:365-377.
51. Schofield L., et al. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 2002, 418:785-789.
52. Deroost K., et al. Improved methods for haemozoin quantification in tissues yield organ- and parasite-specific information in malaria-infected mice. Malar. J. 2012, 11:166.
53. Hunt N.H., Grau G.E. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003, 24:491-499.
54. +-T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice. Infect. Immun. 2001, 69:7341-7348.
55. + T lymphocytes mediate experimental cerebral malaria pathogenesis. J. Immunol. 2003, 170:2221-2228.
56. + T cells is required for the development of experimental cerebral malaria. J. Immunol. 2011, 186:6148-6156.
57. Faille D., et al. Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J. 2009, 23:3449-3458.
58. Liu M., et al. Heme mediated STAT3 activation in severe malaria. PLoS ONE 2012, 7:e34280.
59. Van den Steen P.E., et al. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-?-induced chemokines. Eur. J. Immunol. 2008, 38:1082-1095.
60. Miu J., et al. Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J. Immunol. 2008, 180:1217-1230.
61. Campanella G.S., et al. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:4814-4819.
62. Srivastava K., et al. Platelet factor 4 mediates inflammation in experimental cerebral malaria. Cell Host Microbe 2008, 4:179-187.
63. Nie C.Q., et al. IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog. 2009, 5:e1000369.
64. Senaldi G., et al. Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. Infect. Immun. 1994, 62:1144-1149.
65. + T cell migration to the brain by IFN-? during experimental cerebral malaria. Parasite Immunol. 2008, 30:544-553.
66. Villegas-Mendez A., et al. Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-? during Plasmodium berghei ANKA infection. J. Immunol. 2011, 187:2885-2897.
67. Fauconnier M., et al. IL-12R?2 is essential for the development of experimental cerebral malaria. J. Immunol. 2012, 188:1905-1914.
68. Piguet P.F., et al. Role of the tumor necrosis factor receptor 2 (TNFR2) in cerebral malaria in mice. Lab. Invest. 2002, 82:1155-1166.
69. Ohayon A., et al. Protein kinase C theta deficiency increases resistance of C57BL/6J mice to Plasmodium berghei infection-induced cerebral malaria. Infect. Immun. 2010, 78:4195-4205.
70. Fauconnier M., et al. Protein kinase C-theta is required for development of experimental cerebral malaria. Am. J. Pathol. 2011, 178:212-221.
71. Togbe D., et al. Murine cerebral malaria development is independent of Toll-like receptor signaling. Am. J. Pathol. 2007, 170:1640-1648.
72. Togbe D., et al. Both functional LT? receptor and TNF receptor 2 are required for the development of experimental cerebral malaria. PLoS ONE 2008, 3:e2608.
73. Lacerda-Queiroz N., et al. The role of platelet-activating factor receptor (PAFR) in lung pathology during experimental malaria. Int. J. Parasitol. 2012, 43:11-15.
74. Lacerda-Queiroz N., et al. Platelet-activating factor receptor is essential for the development of experimental cerebral malaria. Am. J. Pathol. 2012, 180:246-255.
75. Piguet P.F., et al. Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice. Infect. Immun. 2000, 68:3822-3829.
76. Faille D., et al. Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding. Thromb. Haemost. 2009, 102:1093-1102.
77. Wassmer S.C., et al. Platelets reorient Plasmodium falciparum-infected erythrocyte cytoadhesion to activated endothelial cells. J. Infect. Dis. 2004, 189:180-189.
78. Cordeiro R.S., et al. Pulmonary edema in mice infected with Plasmodium berghei. Involvement of catecholamines. Experientia 1984, 40:301-302.
79. Cordeiro R.S., et al. Pharmacologically active chemical mediators in Plasmodium berghei malaria. Mem. Inst. Oswaldo Cruz 1986, 81(Suppl. II):251-254.
80. Pena A.C., et al. A novel carbon monoxide-releasing molecule fully protects mice from severe malaria. Antimicrob. Agents Chemother. 2012, 56:1281-1290.
81. Neill A.L., Hunt N.H. Effects of endotoxin and dexamethasone on cerebral malaria in mice. Parasitology 1995, 111:443-454.
82. Warrell D.A., et al. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N. Engl. J. Med. 1982, 306:313-319.
83. Hoffman S.L., et al. High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial. J. Infect. Dis. 1988, 158:325-331.
84. Hiekkanen T., et al. Evolution of plasma proinflammatory cytokines in malaria-related ARDS treated with corticosteroids. Intensive Care Med. 2001, 27:1823-1824.
85. van der Vaart M., Schaaf M.J. Naturally occurring C-terminal splice variants of nuclear receptors. Nucl. Recept. Signal. 2009, 7:e007.
86. Mishra S.K., Newton C.R. Diagnosis and management of the neurological complications of falciparum malaria. Nat. Rev. Neurol. 2009, 5:189-198.
87. Lacerda M.V., et al. Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill?. Clin. Infect. Dis. 2012, 55:e67-e74.
88. Clark I.A., et al. TNF and Plasmodium berghei ANKA-induced cerebral malaria. Immunol. Lett. 1990, 25:195-198.
89. Lucas R., et al. Respective role of TNF receptors in the development of experimental cerebral malaria. J. Neuroimmunol. 1997, 72:143-148.
90. Bauer P.R., et al. Regulation of endothelial cell adhesion molecule expression in an experimental model of cerebral malaria. Microcirculation 2002, 9:463-470.
91. Favre N., et al. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1999, 1:961-968.
92. Grau G.E., et al. TNF-induced microvascular pathology: active role for platelets and importance of the LFA-1/ICAM-1 interaction. Eur. Cytokine Netw. 1993, 4:415-419.
93. Egima C.M., et al. Co-infection with Trypanosoma cruzi protects mice against early death by neurological or pulmonary disorders induced by Plasmodium berghei ANKA. Malar. J. 2007, 6:90.
94. Mueller A.K., et al. Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection model. PLoS ONE 2012, 7:e48110.
95. Moore B.R., et al. Plasmodium berghei: parasite clearance after treatment with dihydroartemisinin in an asplenic murine malaria model. Exp. Parasitol. 2008, 118:458-467.
96. Vanoirbeek J.A., et al. Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am. J. Respir. Cell Mol. Biol. 2010, 42:96-104.
97. Matute-Bello G., et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am. J. Respir. Cell Mol. Biol. 2011, 44:725-738.